BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33085924)

  • 1. The Long Noncoding RNA ZEB2-AS1 Contributes to Proliferation and Epithelial-to-Mesenchymal Transition of Osteosarcoma.
    Yang J; Zou Y; Wu J; Chen B; Luo C; Chen X; Shen H; Luo L
    Cancer Biother Radiopharm; 2023 Nov; 38(9):596-603. PubMed ID: 33085924
    [No Abstract]   [Full Text] [Related]  

  • 2. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2.
    Zhang B; Fan DB; Liu L; Qin Y; Feng DQ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6533-6539. PubMed ID: 32633340
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 6. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
    Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
    Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
    Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
    J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
    Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
    J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
    Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
    Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
    [No Abstract]   [Full Text] [Related]  

  • 10. Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression.
    Wang P; Liu X; Han G; Dai S; Ni Q; Xiao S; Huang J
    Cell Cycle; 2019 Sep; 18(18):2359-2376. PubMed ID: 31387451
    [No Abstract]   [Full Text] [Related]  

  • 11. Over-expression of long non-coding RNA ZEB2-AS1 may predict poor prognosis and promote the migration, invasion, and epithelial-mesenchymal transition of tumor cells in non-small cell lung cancer.
    Xu H; Yu B; Shen W; Jin C; Wang L; Xi Y
    Int J Biol Markers; 2020 Sep; 35(3):29-35. PubMed ID: 32611283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of hsa_circ_0136666 predicts poor prognosis and initiates osteosarcoma tumorigenesis through miR-593-3p/ZEB2 pathway.
    Zhang C; Zhou H; Yuan K; Xie R; Chen C
    Aging (Albany NY); 2020 May; 12(11):10488-10496. PubMed ID: 32424109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB2-AS1 Accelerates Epithelial/Mesenchymal Transition Through miR-1205/CRKL Pathway in Colorectal Cancer.
    Jiang Y; Liu G; Ye W; Xie J; Shao C; Wang X; Li X
    Cancer Biother Radiopharm; 2020 Mar; 35(2):153-162. PubMed ID: 31755734
    [No Abstract]   [Full Text] [Related]  

  • 14. [
    Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer.
    Wu X; Zhu H; Xie Y; Gu X; Zhang L; Huang L
    J BUON; 2020; 25(1):194-201. PubMed ID: 32277632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
    Liu W; Liu P; Gao H; Wang X; Yan M
    Mol Oncol; 2020 Oct; 14(10):2660-2677. PubMed ID: 32412676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway.
    Wang F; Zhu W; Yang R; Xie W; Wang D
    Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMCD1-AS1 Facilitates Cell Proliferation and EMT by Sponging miR-873-3p in Cervical Cancer.
    Liang M; Li Y; Chen C
    Crit Rev Eukaryot Gene Expr; 2023; 33(2):13-25. PubMed ID: 36734854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.